Biomedical subjects
A Halperin
Publications and source records attributed to A Halperin.
The implant-supported overdenture: a practical implant-prosthetic design.
Explore the source record for details and available documents.
Scleroderma-like skin indurations in a child with phenylketonuria: a clinicopathologic correlation and review of the literature.
Scleroderma-like skin lesions are one sequela of phenylketonuria. We describe a child with phenylketonuria and associated dermal connective tissue changes consistent with early inflammatory scleroderma. The severity of the skin lesions apparently waned with dietary restriction of phenylalanine.
Porokeratosis arising in a burn scar.
A histologically verified porokeratosis arose in a burn scar on the back of a 47-year-old man. This phenomenon has not been previously reported. We discuss the literature on porokeratosis, the relation between epidermal and dermal injury, and the genesis of this lesion.
Neurofollicular hamartoma. A clinicopathological study.
We review two patients with unusual pilosebaceous and spindle cell neoplasms. Both lesions were on the nose and were clinically similar to angiofibroma. Immunoperoxidase (S-100 protein, vimentin, immunostain for actin) and special stains (Masson's trichrome, periodic acid-Schiff, and Bielschowsky silver stain) were used to evaluate the lesions. The histologic differential diagnosis included neural nevi, trichogenic myxoma, trichodiscoma, benign neural and vascular tumors, and dermal scar formation. Our patients, we believe, had single asymptomatic smooth, skin-colored papules; this condition was recently termed "neurofollicular hamartoma."
Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertension.
The efficacy and safety of doxazosin (DOX) for the treatment of hypertension was investigated. A multicenter, double-blind, placebo-controlled, parallel design was employed. A 4-week placebo runin period was followed by a 9-week double-blind period during which patients were randomly assigned to placebo or 2, 4, or 8 mg doxazosin. Blood pressures (BP) and heart rates (HR) were measured 24 hours postdose. The mean changes in standing BP (mmHg) were -6.2/-6.9 (2-mg regimen), -5.7/-5.8 (4-mg regimen), -8.5/-7.7 (8-mg regimen) for DOX patients and 0.7/-2.9 for placebo patients. The mean changes in supine BP (mmHg) were -3.2/-4.7 (2-mg regimen), -4.0/-5.1 (4-mg regimen), -4.6/-5.6 (8-mg regimen) for DOX patients and -0.5/-3.3 for placebo patients. There was no evidence of a dose-response relationship for DOX; however, DOX serum levels were linearly related to the dose. Responder rate for the combined DOX patients was 38% (32/84) and for the placebo patients 27% (8/30). HR (24 hours postdose) was not modified by DOX. Patients in the 8-mg regimen had a significantly higher gain in mean body weight (+ 1.3 +/- 0.3 kg; P less than 0.05) compared to the 2-mg regimen, 4-mg regimen, and placebo groups. Plasma norepinephrine was not significantly modified by DOX. DOX had a favorable effect on plasma lipids. DOX lowered LDL cholesterol (P less than 0.05), total cholesterol, and apoprotein B and increased HDL/(LDL + VLDL) ratio (0.05 less than or equal to P less than 0.1) compared to placebo. Dropout rate and treatment-related side effects were equally distributed among the DOX and placebo groups. No patients had the dose of medication reduced because of side effects. Three DOX patients were withdrawn because of postural dizziness.
The use of frozen sections during gastrointestinal endoscopy.
Explore the source record for details and available documents.
Restraint, anticipated consumption, and overeating.
Explore the source record for details and available documents.
[Hydatid parahilar cyst. A technic].
Explore the source record for details and available documents.
[Postsurgical costal chondritis].
Explore the source record for details and available documents.